Nexentis Technologies (NXTS) Stock Price, News & Analysis

Company Overview

N2OFF, Inc., an agri-food tech company, engages in the development and sale of eco-friendly green solutions for the food industry to enhance food safety and shelf life of fresh produce. Its products are based on proprietary blend of food acids combined with various oxidizing agent-based sanitizers and low concentrated fungicides for cleaning, sanitizing, and controlling pathogens on fresh produce that are safer for human consumption and extend their shelf life by reducing their decay. The company's products include SavePROTECT or PeroStar, a processing aid for post-harvest application that is added to fruit and vegetable wash water; and SF3HS and SF3H, a post-harvest cleaning and sanitizing solution to control plant and foodborne pathogens. It also offers SpuDefender for controlling post-harvest potato sprouts; and FreshProtect to control spoilage-creating microorganisms on post-harvest citrus fruit. The company was formerly known as Save Foods, Inc. and changed its name to N2OFF, Inc. in March 2024. N2OFF, Inc. was incorporated in 2009 and is headquartered in Hod HaSharon, Israel.

Key Stats

• Today's Range: $1.41 to $1.50
• 50-Day Range: $1.31 to $2.07
• 52-Week Range: $1.14 to $49.00
• Volume: 4,574 shs
• Average Volume: 487,861 shs
• Market Capitalization: $2.10 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Nexentis Technologies Stock Analysis - MarketRank™

Nexentis Technologies scored higher than 21% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Nexentis Technologies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Nexentis Technologies has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Nexentis Technologies is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Nexentis Technologies is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Nexentis Technologies has a P/B Ratio of 0.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.91% of the float of Nexentis Technologies has been sold short.

Short Interest Ratio / Days to Cover

Nexentis Technologies has a short interest ratio ("days to cover") of 2.25, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Nexentis Technologies has recently decreased by 24.80%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Nexentis Technologies does not currently pay a dividend.

Dividend Growth

Nexentis Technologies does not have a long track record of dividend growth.

News and Social Media

• Score: 2.0 / 5
• News Sentiment: 0.21

News Sentiment

Nexentis Technologies has a news sentiment score of 0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Nexentis Technologies this week, compared to 2 articles on an average week.

MarketBeat Follows

1 people have added Nexentis Technologies to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Nexentis Technologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

6.52% of the stock of Nexentis Technologies is held by insiders.

Percentage Held by Institutions

61.24% of the stock of Nexentis Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 11/13/2025
• Today: 10/02/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:NXTS
• Previous Symbol: NASDAQ:NITO
• CIK: 1789192
• Web: nexentistech.com
• Phone: +972544561349
• Fax: N/A
• Employees: 9
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($96.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$4 million
• Net Margins: N/A
• Pretax Margin: -25,363.63%
• Return on Equity: -304.79%
• Return on Assets: -178.91%

Debt

• Debt-to-Equity Ratio: 0.12
• Current Ratio: 3.72
• Quick Ratio: 3.72

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $39.70 per share
• Price / Book: 0.04

Miscellaneous

• Outstanding Shares: 1,453,000
• Free Float: 1,358,000
• Market Cap: $2.09 million
• Optionable: N/A
• Beta: 1.85